“Massachusetts-based Moderna announced that its initial vaccine trial has shown that subjects have developed antibodies for COVID-19. While the experiment is of limited scale the encouraging results have sent stocks rallying. The next phase is due in July.”
“Markets are encouraged by the message due out by Jerome Powell, Chairman of the Fed. In his prepared remarks, Powell pledged to keep rates low until the US returns to full employment and his tone was more optimistic than in an interview over the weekend.”
“Germany and France agreed to boost EU fiscal support by €500 billion, coming from new debt raised by the European Commission and distributed as grants. The accord still awaits approval yet the news also contributed to a better mood and pushed the greenback lower.”
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.